Neuropathix (TYGS) Annual Balance Sheets

Annual · GAAP · USD millions
Access TYGS quarterly Balance Sheets →
From Neuropathix through Dec 31 2017, shifts in Dec 31 2021's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent0.02
Security Deposit0.02
Marketable Securities, Current SH0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Receivables0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.12
Total Current Assets0.16
Equipment/Property/Plant Net0.07
Financial Instruments0.00
Other Assets, Noncurrent0.00
Total Assets0.22
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.80
Accrued Liabilities, Current AC0.53
Derivative Liability, Current DE0.09
Short-term Debt0.91
Other Liabilities, Current0.54
Deferred Revenue, Current DE0.11
Total Current Liabilities2.98
Long-term debt0.38
Capital Lease Obligations, Noncurrent LO0.02
Convertible Debt LO0.14
Total Long-term Debt0.54
Derivative Liability, Noncurrent DE0.34
Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs0.38
Other liabilities, Noncurrent0.00
Total Liabilities4.21
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock12.60
Retained Earnings / Accumulated Deficit-16.59
Other Equity0.00
Common Stockholder's Equity-3.99
Non-controlling interests & other0.00
Total Stockholder's Equity-3.99
Liabilities & Stockholder's Equity0.22
4 historic quarters locked

Sign in to unlock the full Neuropathix balance sheet history.

About Neuropathix Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001607062-22-000388

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.